Activation of the cyclic AMP pathway by α-melanotropin mediates the response of human melanocytes to ultraviolet B radiation

Cancer Research

Volumn 58, Issue 1, 1998, Pages 47-54

  Im, Sungbin ^a,e   Moro, Osamu ^b   Peng, Fuping ^a   Medrano, Estela E ^c   Cornelius, James ^d   Babcock, George ^d   Nordlund, James J ^a   Abdel Malek, Zalfa A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b SHISEIDO RESEARCH CENTER   (Japan)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

^e Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; CORTICOTROPIN; CYCLIC AMP; PROTEIN BCL 2; PROTEIN P21; RETINOBLASTOMA PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MELANOMA; MITOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION CARCINOGENESIS; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; ULTRAVIOLET B RADIATION;

ALPHA-MSH; CYCLIC AMP; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; HUMANS; MALE; MELANOCYTES; MEMBRANE GLYCOPROTEINS; MONOPHENOL MONOOXYGENASE; OXIDOREDUCTASES; PHOSPHORYLATION; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0031963866     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Friedmann, P. S., and Gilchrest, B. A. Ultraviolet radiation directly induces pigment production by cultured human melanocytes. J. Cell. Physiol., 133: 88-94, 1987.
2. Abdel-Malek, Z., Swope, V., Smalara, D., Babcock, G., Dawes, S., and Nordlund, J. Analysis of the UV induced melanogenesis and growth arrest of human melanocytes. Pigment Cell Res., 7: 326-332, 1994.
3. Barker, D., Dixon, K., Medrano, E. E., Smalara, D., Im, S., Mitchell, D., Babcock, G., and Abdel-Malek, Z. A. Comparison of the responses of human melanocytes with different melanin contents to ultraviolet B irradiation. Cancer Res., 55: 4041-4046, 1995.
4. Mitchell, D. L. The relative cytotoxicity of (6-4) photoproducts and cyclobutane dimers in mammalian cells. Photochem. Photobiol., 48: 51-57, 1988.
5. Imokawa, G., Yada, Y., and Miyagishi, M. Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J. Biol. Chem., 267: 24675-24680, 1992.
6. Grenfell, S. J., Smithers, N., and Solari, R. Acute upregulation of interleukin-1 receptor by ligand. Cytokine, 4: 114-124, 1992.
7. Sherbrooke, W. C., Hadley, M. E., and Castrucci, A. M. L. Melanotropic peptides and receptors: an evolutionary perspective in vertebrate physiologic color change. In: M. E. Hadley (ed.), Melanotropic Peptides. Vol. II, pp. 175-190. Washington: CRC Press, 1988.
8. Thody, A. J., Ridley, K., Penny, R. J., Chalmers, R., Fisher, C., and Shuster, S. MSH peptides are present in mammalian skin. Peptides, 4: 813-816, 1983.
9. Schauer, E., Trautinger, F., Kock, A., Schwarz, A., Bhardwaj, R., Simon, M., Ansel, J. C., Schwarz, T., and Luger, T. A. Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J. Clin. Invest., 93: 2258-2262, 1994.
10. Chakraborty, A. K., Funasaka, Y., Slominski, A., Ermak, G., Hwang, J., Pawelek, J. M., and Ichihashi, M. Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim. Biophys. Acta, 1313: 130-138, 1996.
11. Halaban, R., Langdon, R., Birchall, N., Cuono, C., Baird, A., Scott, G., Moellmann, G., and McGuire, J. Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J. Cell Biol., 107: 1611-1619, 1988.
12. Imokawa, G., Yada, Y., and Miyagishi, M. Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J. Biol. Chem., 267: 24675-24680, 1992.
13. Altmeyer, P., Stöhr, L., and Holzmann, H. Seasonal rhythm of the plasma level of alpha-melanocyte stimulating hormone. J. Invest. Dermatol., 86: 454-456, 1986.
14. Pawelek, J. M., Chakraborty, A. K., Osber, M. P., Orlow, S. J., Min, K. K., Rosenzweig, K. E., and Bolognia, J. L. Molecular cascades in UV-induced melanogenesis: a central role for melanotropins? Pigment Cell Res., 5: 348-356, 1992.
15. Chakraborty, A. K., Orlow, S. J., Bolognia, J. L., and Pawelek, J. M. Structural/ functional relationships between internal and external MSH receptors: modulation of expression in Cloudman melanoma cells by UVB radiation. J. Cell. Physiol., 147: 1-6, 1991.
16. Abdel-Malek, Z., Swope, V. B., Suzuki, I., Akcali, C., Harriger, M. D., Boyce, S. T., Urabe, K., and Hearing, V. J. Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc. Natl. Acad. Sci. USA, 92: 1789-1793, 1995.
17. 7α-MSH affect morphology, tyrosinase activity and melanogenesis in cultured human melanocytes. J. Cell Sci., 107: 205-211, 1994.
18. Hunt, G., Todd, C., Kyne, S., and Thody, A. J. ACTH stimulates melanogenesis in cultured human melanocytes. J. Endocrinol., 140: R1-R3, 1994.
19. De Luca, M., Siegrist, W., Bondanza, S., Mathor, M., Cancedda, R., and Eberle, A. N. αMelanocyte stimulating hormone (αMSH) stimulates normal human melanocyte growth by binding to high-affinity receptors. J. Cell Sci., 105: 1079-1084, 1993.
20. 7 α-Melanocyte-stimulating hormone increases the eumelanin:Phaeomelanin ratio in cultured human melanocytes. J. Invest. Dermatol., 104: 83-85, 1995.
21. Chedekel, M. R., Smith, S. K., Post, P. W., Pokora, A., and Vessell, D. L. Photodestruction of pheomelanin: role of oxygen. Proc. Natl. Acad. Sci. USA. 75: 5395-5399, 1978.
22. Menon, I. A., Persad, S., Ranadive, N. S., and Haberman, H. F. Photobiological effects of eumelanin and pheomelanin. In: J. T. Bagnara, S. N. Klaus, E. Paul, and M. Schartl (eds.), Biological, Molecular and Clinical Aspects of Pigmentation, pp. 77-86. Tokyo: University of Tokyo Press, 1985.
23. Suzuki, I., Cone, R., Im, S., Nordlund, J., and Abdel-Malek, Z. Binding capacity and activation of the MC1 receptors by melanotropic hormones correlate directly with their mitogenic and melanogenic effects on human melanocytes. Endocrinology, 137: 1627-1633, 1996.
24. Mountjoy, K. G., Robbins, L. S., Mortrud, M. T., and Cone, R. D. The cloning of a family of genes that encode the melanocortin receptors. Science (Washington DC), 257: 1248-1251, 1992.
25. Valverde, P., Healy, E., Jackson, I., Rees, J. L., and Thody, A. J. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat. Genet., 11: 328-330, 1995.
26. Valverde, P., Healy, E., Sikkink, S., Haldane, F., Thody, A. J., Carothers, A., Jackson, I. J., and Rees, J. L. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum. Mol. Genet., 5: 1663-1666, 1996.
27. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
28. Ullrich, S. L. Anderson, C. W., Mercer, W. E., and Appella, E. The p53 tumor suppressor protein, a modulator of cell proliferation. J. Biol. Chem., 267: 15259-15262, 1992.
29. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
30. Hinds, P. W. The retinoblastoma tumor suppressor protein. Curr. Opin. Genet. Dev., 5: 79-83, 1995.
31. Reed, J. C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol., 124: 1-6, 1994.
32. Miyashita, T., Krajewski, S., Krajewska, M., Wang, H. G., Lin, H. K., Liebermann, D. A., Hoffman, B., and Reed, J. C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9: 1799-1805, 1994.
33. Waf-1/SDI/Cip-1 protein. Cancer Res., 55: 4047-4052, 1995.
34. Swope, V. B., Medrano, E. E., Smalara, D., and Abdel-Malek, Z. Long-term proliferation of human melanocytes is supported by the physiologic mitogens α-melanotropin, endothelin-1, and basic fibroblast growth factor. Exp. Cell Res., 2/7: 453-459, 1995.
35. Medrano, E. E., and Nordlund, J. J. Successful culture of adult human melanocytes from normal and vitiligo donors. J. Invest. Dermatol., 95: 441-445, 1990.
36. 3H assay for tyrosinase development in skin of newborn hamsters. Science (Washington DC), 164: 838-839, 1969.
37. 2 determined by using a bromodeoxyuridine method of DNA analysis. J. Cell. Physiol., 136: 247-256, 1988.
38. Hearing, V. J., and Tsukamoto, K. Enzymatic control of pigmentation in mammals. FASEB J., 5: 2902-2909, 1991.
39. Kobayashi, T., Urabe, K., Winder, A. J., Jiménez-Cervantes, C., Imokawa, G., Brewington, T., Solano, F., García-Borrón, J. C., and Hearing, V. J. Tyrosinase-related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis. EMBO J., 13: 5818-5825, 1994.
40. Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., and Nishizuka, Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J. Biol. Chem., 257: 7847-7851, 1982.
41. Arita, Y., O'Driscoll, K. R., and Weinstein, I. B. Growth of human melanocyte cultures supported by 12-O-tetradecanoylphorbol-13-acetate is mediated through protein kinase C activation. Cancer Res., 52: 4514-4521, 1992.
42. Buchkovich, K., Duffy, L. A., and Harlow, E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell, 58: 1097-1105, 1989.
43. DeCaprio, J. A., Furukawa, Y., Ajchenbaum, F., Griffin, J. D., and Livingston, D. M. The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc. Natl. Acad. Sci. USA, 89: 1795-1798, 1992.
44. Harper, J. W., and Elledge, S. J. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev., 6: 56-64, 1996.
45. Forbes, P. D., Davis, R. E., and Urbach, F. Experimental ultraviolet carcinogenesis. In: A. Castellani (ed.), Research in Photobiology, pp. 469-478. New York: Plenum Publishing Corp., 1976.
46. Fitzpatrick, T. B., Sober, A. J., Pearson, B. J., and Lew, R. Cutaneous carcinogenic effects of sunlight in humans. In: A. Castellani (ed.), Research in Photobiology, pp. 485-490. New York: Plenum Publishing Corp., 1976.
47. Epstein, J. H. Photocarcinogenesis, skin cancer and aging. J. Am. Acad. Dermatol., 9: 487-502, 1983.
48. Glass, A. G., and Hoover, R. N. The emerging epidemic of melanoma and squamous cell skin cancer. J. Am. Med. Assoc., 262, 2097-2100, 1989.
49. Setlow, R. B. The wavelengths in sunlight effective in producing skin cancer: a theoretical analysis. Proc. Natl. Acad. Sci. USA, 71: 3363-3366, 1974.
50. Pathak, M. A., Jimbow, K., and Fitzpatrick, T. Photobiology of pigment cells. In: M. Seiji (ed.), Phenotypic Expression in Pigment Cells, pp. 655-670. Tokyo: University of Tokyo Press, 1980.
51. Kaidbey, K. H., Poh Agin, P., Sayre, R. M., and Kligman, A. M. Photoprotection by melanin-a comparison of black and Caucasian skin. J. Am. Acad. Dermatol., 1: 249-260, 1979.
52. Bustamante, J., Bredeston, L., Malanga, G., and Mordoh, J. Role of melanin as a scavenger of active oxygen species. Pigment Cell Res., 6: 348-353, 1993.
53. Ziegler, A., Jonason, A. S., Leffell, D. J., Simon, J. A., Sharma, H. W., Kimmelman, J., Remington, L., Jacks, T., and Brash, D. E. Sunburn and p53 in the onset of skin cancer. Nature (Lond.), 372: 773-776, 1994.
54. Bates, S., and Vousden, K. H. p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev., 6: 12-19, 1996.
55. Liu, Z-G., Baskaran, R., Lea-Chou, E. T., Wood, L. D., Chen, Y., Karin, M., and Wang, J. Y. J. Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature (Lond.), 384: 273-276, 1996.
56. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
57. Poon, R. Y. C., Jiang, W., Toyoshima, H., and Hunter, T. Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage. J. Biol. Chem., 271: 13283-13291, 1996.
58. Waga, S., Hannon, G. J., Beach, D., and Stillman, B. The p21 cyclin-dependent kinase inhibitor directly controls DNA replication via interaction with PCNA. Nature (Lond.), 369: 574-578, 1994.
59. Garcia, I., Martinou, I., Tsujimoto, Y., and Martinou, J-C. Prevention of programmed cell death of sympathetic neurons by the Bcl-2 proto-oncogene. Science (Washington DC), 258: 302-304, 1992.
60. Flaws, J. A., DeSanti, A., Tilly, K. I., Javid, R. O., Kugu, K., Johnson, A. L., Hirshfield, A. N., and Tilly, J. L. Vasoactive intestinal peptide-mediated suppression of apoptosis in the ovary: potential mechanisms of action and evidence of a conserved antiatretogenic role through evolution. Endocrinology, 136: 4351-4359, 1995.